Table 2 KEGG pathway enrichment.
Pathway Name | Match Status | p | FDR |
|---|---|---|---|
Control vs Stroke | |||
Biosynthesis of unsaturated fatty acids | 1/74 | 0.0299 | 0.0299 |
Glycerolipid metabolism | 2/38 | 0.0003 | 0.0009 |
Phosphonate and phosphinate metabolism | 1/56 | 0.0177 | 0.0191 |
Glycerophospholipid metabolism | 3/56 | 0.0000 | 0.0003 |
Choline metabolism in cancer | 2/11 | 0.0000 | 0.0001 |
Sphingolipid metabolism | 1/35 | 0.0072 | 0.0091 |
Fatty acid elongation | 1/40 | 0.0093 | 0.0108 |
Leukoaraiosis patients vs Stroke patients with leukoaraiosis | |||
Glycerolipid metabolism | 2/38 | 0.0010 | 0.0025 |
Glycerophospholipid metabolism | 3/56 | 0.0002 | 0.0007 |
Fatty acid biosynthesis | 1/58 | 0.0389 | 0.0423 |
Sphingolipid metabolism | 1/35 | 0.0151 | 0.0191 |
Cholesterol metabolism | 2/10 | 0.0000 | 0.0002 |
Adipocytokine signaling pathway | 2/7 | 0.0000 | 0.0001 |
Fatty acid elongation | 1/40 | 0.0195 | 0.0239 |